BioNTech SE
Latest round
- Series B
Last raised
- Jul 2019
Total raised
- $619M
Investors
- 12
About BioNTech SE
Founded in 2008 in Mainz, Germany, BioNTech SE focuses on developing targeted immunotherapies and mRNA vaccines. The company was co-founded by Christoph Huber and Ugur Sahin, who have backgrounds in biopharmaceutical innovation.BioNTech concentrates on creating innovative immunotherapies and mRNA vaccines that aim to improve global health outcomes. Their oncology portfolio features three therapeutic modalities: mRNA cancer immunotherapies, next-generation immunomodulators, and targeted therapies, all designed for precise cancer cell targeting. The company’s mRNA vaccine technology gained prominence with their COVID-19 vaccine, establishing a strong presence in the infectious diseases sector.BioNTech aims to expand its product pipeline with upcoming launches in cancer immunotherapy and infectious disease vaccines. The company is exploring new markets in Asia and Latin America, with planned expansions through 2024.
Who invested in BioNTech SE
12 investors across 3 rounds
See all investors in BioNTech SE
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about BioNTech SE
Who invested in BioNTech SE?
BioNTech SE has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioNTech SE raised?
BioNTech SE has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did BioNTech SE last raise money?
BioNTech SE's most recent round on record is a Series B, in Jul 2019.
What does BioNTech SE do?
Founded in 2008 in Mainz, Germany, BioNTech SE focuses on developing targeted immunotherapies and mRNA vaccines.
Where is BioNTech SE headquartered?
BioNTech SE is headquartered in Mainz, Germany.
Which VCs invest in companies like BioNTech SE?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at BioNTech SE's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like BioNTech SE? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.